SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-026878
Filing Date
2024-03-28
Accepted
2024-03-28 07:15:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0202788-424b3_hoththera.htm 424B3 9018
2 GRAPHIC image_001.jpg GRAPHIC 3425
  Complete submission text file 0001213900-24-026878.txt   14910
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269224 | Film No.: 24793480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)